<VariationArchive VariationID="468353" VariationName="NM_005029.4(PITX3):c.640_656dup (p.Gly220fs)" VariationType="Duplication" Accession="VCV000468353" Version="19" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2017-12-26" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="459553" VariationID="468353">
      <GeneList>
        <Gene Symbol="GBF1" FullName="golgi brefeldin A resistant guanine nucleotide exchange factor 1" GeneID="8729" HGNC_ID="HGNC:4181" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102230643" stop="102382896" display_start="102230643" display_stop="102382896" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104005254" stop="104142655" display_start="104005254" display_stop="104142655" Strand="+" />
          </Location>
          <OMIM>603698</OMIM>
        </Gene>
        <Gene Symbol="PITX3" FullName="paired like homeodomain 3" GeneID="5309" HGNC_ID="HGNC:9006" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102230189" stop="102241512" display_start="102230189" display_stop="102241512" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="103989945" stop="104001230" display_start="103989945" display_stop="104001230" Strand="-" />
          </Location>
          <OMIM>602669</OMIM>
          <Haploinsufficiency last_evaluated="2013-11-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PITX3">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-11-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PITX3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005029.4(PITX3):c.640_656dup (p.Gly220fs)</Name>
      <CanonicalSPDI>NC_000010.11:102230766:CCCAGGCCCTGCAGGGCCCCAGGCCCTG:CCCAGGCCCTGCAGGGCCCCAGGCCCTGCAGGGCCCCAGGCCCTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q24.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102230766" stop="102230767" display_start="102230766" display_stop="102230767" variantLength="17" positionVCF="102230766" referenceAlleleVCF="G" alternateAlleleVCF="GCCCAGGCCCTGCAGGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="103990523" stop="103990524" display_start="103990523" display_stop="103990524" variantLength="17" positionVCF="103990523" referenceAlleleVCF="G" alternateAlleleVCF="GCCCAGGCCCTGCAGGGC" />
      </Location>
      <ProteinChange>G220fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.103990535_103990551dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.103990535_103990551dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.102230778_102230794dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.102230778_102230794dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008147.1" sequenceAccession="NG_008147" sequenceVersion="1" change="g.15692_15708dup">
            <Expression>NG_008147.1:g.15692_15708dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005029.4" sequenceAccession="NM_005029" sequenceVersion="4" change="c.640_656dup" MANESelect="true">
            <Expression>NM_005029.4:c.640_656dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005020.1" sequenceAccession="NP_005020" sequenceVersion="1" change="p.Gly220fs">
            <Expression>NP_005020.1:p.Gly220fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658658008" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602669.0001" DB="OMIM" />
        <XRef Type="rs" ID="1411557416" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005029.4(PITX3):c.640_656dup (p.Gly220fs) AND not provided" Accession="RCV000627511" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005029.4(PITX3):c.640_656dup (p.Gly220fs) AND ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES" Accession="RCV002294347" Version="8">
        <ClassifiedConditionList TraitSetID="34915">
          <ClassifiedCondition DB="MedGen" ID="C4310917">ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005029.4(PITX3):c.640_656dup (p.Gly220fs) AND Cataract 11, posterior polar" Accession="RCV002294346" Version="8">
        <ClassifiedConditionList TraitSetID="9866">
          <ClassifiedCondition DB="MedGen" ID="C3807150">Cataract 11, posterior polar</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005029.4(PITX3):c.640_656dup (p.Gly220fs) AND Cataract 11 multiple types" Accession="RCV003333078" Version="2">
        <ClassifiedConditionList TraitSetID="1913">
          <ClassifiedCondition DB="MedGen" ID="C1864567">Cataract 11 multiple types</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-15" NumberOfSubmissions="6" NumberOfSubmitters="5" DateCreated="2017-12-26" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10361984</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15286169</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17888164</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18989383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24555714</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29405783</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6801987</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9620774</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="34915" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="36836" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES</ElementValue>
                <XRef Type="Allelic variant" ID="602669.0001" DB="OMIM" />
              </Name>
              <XRef ID="C4310917" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9866" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17876" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cataract 11, posterior polar</ElementValue>
              </Name>
              <XRef ID="C3807150" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1913" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="699" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cataract, posterior polar, 4</ElementValue>
                <XRef ID="Cataract%2C+Posterior+Polar%2C+4/1159" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cataract 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cataract 11 multiple types</ElementValue>
                <XRef ID="MONDO:0012527" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CTPP4</ElementValue>
                <XRef Type="MIM" ID="610623" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPP4</ElementValue>
                <XRef Type="MIM" ID="610623" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CTRCT11</ElementValue>
                <XRef Type="MIM" ID="610623" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10228" />
                <XRef ID="10228" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="91492" DB="Orphanet" />
              <XRef ID="C1864567" DB="MedGen" />
              <XRef ID="MONDO:0012527" DB="MONDO" />
              <XRef Type="MIM" ID="610623" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="117936" SubmissionDate="2017-01-26" DateLastUpdated="2017-01-30" DateCreated="2013-05-25">
        <ClinVarSubmissionID localKey="602669.0001_CATARACT 11, POSTERIOR POLAR" title="PITX3, 17-BP DUP, NT657_CATARACT 11, POSTERIOR POLAR" />
        <ClinVarAccession Accession="SCV000071246" DateUpdated="2017-01-30" DateCreated="2013-05-25" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Anterior Segment Dysgenesis 1, Multiple Subtypes</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 6 affected members of a 6-generation family with autosomal dominant anterior segment mesenchymal dysgenesis (ASGD1; 107250) and cortical cataract, previously described by Hittner et al. (1982), Semina et al. (1998) identified a 17-bp insertion in exon 4 of the PITX3 gene, resulting in a frameshift and altering 82 C-terminal amino acids that collectively represent more than one-quarter of the total protein length of 302 amino acids. The region of insertion lies outside the homeodomain but includes the 14-amino acid motif that is conserved among all of the PITX proteins and some other paired-like homeoproteins. The mutation segregated with disease and was not found in 300 control chromosomes. There was marked variability in the phenotype, which was characterized by corneal and lens opacities of variable degree, with optic nerve abnormalities noted in 3 patients.</Attribute>
              <Citation>
                <ID Source="PubMed">6801987</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9620774</ID>
              </Citation>
              <XRef DB="OMIM" ID="107250" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In all clinically affected members of a large Australian kindred segregating anterior segment abnormalities, including Peters anomaly with corneal clouding, iridolenticular corneal adhesions, displaced Schwalbe line, and cataract, previously reported by Withers et al. (1999), Summers et al. (2008) identified heterozygosity for the 17-bp duplication in the PITX3 gene. Noting that there was no difference in the size of the duplication between severely affected and more mildly affected individuals, the authors suggested the existence of modifier loci.</Attribute>
              <Citation>
                <ID Source="PubMed">10361984</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18989383</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Cataract 11, Posterior Polar</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 4 large unrelated families with autosomal dominant posterior polar cataract (CTRCT11; 610623), 3 of English descent and 1 of Chinese descent, Berry et al. (2004) identified heterozygosity for a 17-bp duplication at nucleotide 657 of the PITX3 gene. In one 4-generation English family, 1 of the 10 affected members also had ASMD, but her affected daughter, who had the same 17-bp duplication, had only cataract. In another 4-generation English family, 4 of 11 affected members also had ASMD, but in the remaining 6-generation English family and 4-generation Chinese family, none of those affected had any other abnormalities. Berry et al. (2004) suggested that cataract, rather than ASMD, may be the major feature of PITX3 mutations, and that there may be another gene causing ASMD. Berry et al. (2004) noted that sequence analysis indicated that this mutation, originally reported as an insertion, is actually a duplication; the mutation was not found in 100 healthy individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">15286169</ID>
              </Citation>
              <XRef DB="OMIM" ID="610623" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PITX3" />
          </GeneList>
          <Name>PITX3, 17-BP DUP, NT657</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">17-BP DUP, NT657</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602669.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">CATARACT 11, POSTERIOR POLAR</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27547" SubmissionDate="2017-01-26" DateLastUpdated="2017-01-30" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602669.0001_ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES" title="PITX3, 17-BP DUP, NT657_ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES" />
        <ClinVarAccession Accession="SCV000027547" DateUpdated="2017-01-30" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Anterior Segment Dysgenesis 1, Multiple Subtypes</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 6 affected members of a 6-generation family with autosomal dominant anterior segment mesenchymal dysgenesis (ASGD1; 107250) and cortical cataract, previously described by Hittner et al. (1982), Semina et al. (1998) identified a 17-bp insertion in exon 4 of the PITX3 gene, resulting in a frameshift and altering 82 C-terminal amino acids that collectively represent more than one-quarter of the total protein length of 302 amino acids. The region of insertion lies outside the homeodomain but includes the 14-amino acid motif that is conserved among all of the PITX proteins and some other paired-like homeoproteins. The mutation segregated with disease and was not found in 300 control chromosomes. There was marked variability in the phenotype, which was characterized by corneal and lens opacities of variable degree, with optic nerve abnormalities noted in 3 patients.</Attribute>
              <Citation>
                <ID Source="PubMed">6801987</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9620774</ID>
              </Citation>
              <XRef DB="OMIM" ID="107250" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In all clinically affected members of a large Australian kindred segregating anterior segment abnormalities, including Peters anomaly with corneal clouding, iridolenticular corneal adhesions, displaced Schwalbe line, and cataract, previously reported by Withers et al. (1999), Summers et al. (2008) identified heterozygosity for the 17-bp duplication in the PITX3 gene. Noting that there was no difference in the size of the duplication between severely affected and more mildly affected individuals, the authors suggested the existence of modifier loci.</Attribute>
              <Citation>
                <ID Source="PubMed">10361984</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18989383</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Cataract 11, Posterior Polar</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In affected members of 4 large unrelated families with autosomal dominant posterior polar cataract (CTRCT11; 610623), 3 of English descent and 1 of Chinese descent, Berry et al. (2004) identified heterozygosity for a 17-bp duplication at nucleotide 657 of the PITX3 gene. In one 4-generation English family, 1 of the 10 affected members also had ASMD, but her affected daughter, who had the same 17-bp duplication, had only cataract. In another 4-generation English family, 4 of 11 affected members also had ASMD, but in the remaining 6-generation English family and 4-generation Chinese family, none of those affected had any other abnormalities. Berry et al. (2004) suggested that cataract, rather than ASMD, may be the major feature of PITX3 mutations, and that there may be another gene causing ASMD. Berry et al. (2004) noted that sequence analysis indicated that this mutation, originally reported as an insertion, is actually a duplication; the mutation was not found in 100 healthy individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">15286169</ID>
              </Citation>
              <XRef DB="OMIM" ID="610623" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PITX3" />
          </GeneList>
          <Name>PITX3, 17-BP DUP, NT657</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">17-BP DUP, NT657</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602669.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1457225" SubmissionDate="2019-01-29" DateLastUpdated="2018-05-21" DateCreated="2018-05-21">
        <ClinVarSubmissionID localKey="GDX:1994714|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000748511" DateUpdated="2018-05-21" DateCreated="2018-05-21" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.640_656dup17 variant in the PITX3 gene is the most common PITX3 pathogenic variant and has been reported to segregate with ocular disorders in multiple unrelated families (Semina et al., 1998; Verdin et al., 2014; Zazo Seco et al., 2018). The c.640_656dup17 variant causes a frameshift starting with codon Glycine 220, changes this amino acid to a Proline residue, and creates a premature Stop codon at position 95 of the new reading frame, denoted p.Gly220ProfsX95. This frameshift variant replaces the typical last 83 amino acid residues in the PITX3 protein with 94 different amino acid residues. Functional studies of eye cells transfected with the c.640_656dup17 variant (described as G219fs due to alternative nomenclature) demonstrated a decrease in the transactivation activity of the PITX3 protein compared to wild-type cells (Sakazume et al., 2007). Additional functional studies suggested that this variant impairs PITX3-DNA binding (Sakazume et al., 2007). The c.640_656dup17 variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.640_656dup17 as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PITX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="CCCAGGCCCTGCAGGGCCCCAGGCCCTGCAGGGC" referenceAllele="CCCAGGCCCTGCAGGGC" start="103990523" stop="103990524" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005029.3:c.640_656dup17</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3110540" SubmissionDate="2022-05-04" DateLastUpdated="2023-04-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4887488|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001584894" DateUpdated="2023-04-09" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9620774</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15286169</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24555714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29405783</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17888164</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24555714</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the PITX3 gene (p.Gly220Profs*95). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 83 amino acid(s) of the PITX3 protein and extend the protein by 11 additional amino acid residues. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This frameshift has been observed in individuals with congenital cataracts (PMID: 9620774, 15286169, 24555714, 29405783). It has also been observed to segregate with disease in related individuals. This variant is also known as 657ins17. ClinVar contains an entry for this variant (Variation ID: 468353). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this frameshift affects PITX3 function (PMID: 17888164, 24555714). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PITX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.103990523_103990524insCCCAGGCCCTGCAGGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7562607" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="48539|OMIM:610623" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004041113" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005029.4:c.640_656dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610623" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13858665</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5051953" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-10-22">
        <ClinVarSubmissionID localKey="120330|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002585250" DateUpdated="2024-07-15" DateCreated="2022-10-22" Type="SCV" Version="12" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PITX3: PP1:Strong, PM2, PVS1:Moderate, PP4, PS3:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PITX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GCCCAGGCCCTGCAGGGC" referenceAllele="G" start="103990523" stop="103990523" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3110540" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1457225" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27547" TraitType="Disease" MappingType="Name" MappingValue="ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES" MappingRef="Preferred">
        <MedGen CUI="C4310917" Name="ANTERIOR SEGMENT DYSGENESIS 1, MULTIPLE SUBTYPES" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5051953" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7562607" TraitType="Disease" MappingType="XRef" MappingValue="610623" MappingRef="OMIM">
        <MedGen CUI="C1864567" Name="Cataract 11 multiple types" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="117936" TraitType="Disease" MappingType="Name" MappingValue="CATARACT 11, POSTERIOR POLAR" MappingRef="Alternate">
        <MedGen CUI="C3807150" Name="Cataract 11, posterior polar" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

